semaglutide and hfpef Potential action mechanisms of in the phenotype of heart Evaluating the Cardiovascular Benefits of

Start your intake How GLP-1 Medications Affect the Brain and Mood GLP-1 receptors exist throughout the central and peripheral nervous systems, not just in appetite centers

However, because this eye color change is not a medical concern, its important to continue your treatment and weigh the risks and benefits with your doctor before switching to another option

2 This means the medication may not work effectively, may cause serious health problems or in some cases may be life-threatening

Driving Adherence Patient success with GLP-1 therapy often depends on consistent adherence, an area where digital health tools shine: Mobile health apps: Push notifications, reminders, and progress tracking help patients stay on top of their treatment plans

As a cardiologist who cares deeply about prevention, I am thrilled to have a medication that helps my patients achieve their weight loss goals, while reducing their risk for type 2 diabetes, and improving their cardiovascular risk factors

Heres what clinical research tells us about typical weight loss outcomes over time in terms of average percentage of weight lost with liraglutide 3 mg and semaglutide 2.4 mg: After 3 months: After 1 year: Everyones timeline looks a little different